Prolactin, menstrual irregularities, quality of life

Schizophrenia Research

Volumn 91, Issue 1-3, 2007, Pages 270-271

  Wong, J ^a   Seeman, M V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

AMENORRHEA; BODY MASS; BONE DENSITY; GALACTORRHEA; GYNECOMASTIA; HUMAN; HYPERPROLACTINEMIA; IMMUNE SYSTEM; INFERTILITY; LETTER; MENSTRUAL IRREGULARITY; OLIGOMENORRHEA; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SEXUAL DYSFUNCTION;

ADULT; AMENORRHEA; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; LIBIDO; PSYCHOTIC DISORDERS; QUALITY OF LIFE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 33847302920     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.11.004     Document Type: Letter

References (4)

1. Canuso C.M., Goldstein J.M., Wojcik J., Dawson R., Brandman D., Klibanski A., Schildkraut J.J., and Green A.I. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res. 111 (2002) 11-20
2. Meaney A.M., Smith S., Howes O.D., O'brien M., Murray R.M., and O'keane V. Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br. J. Psychiatry 184 (2004) 503-508
3. Rijcken C.A., Monster T.B., Brouwers J.R., and de Jong-van den Berg L.T. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?. J. Clin. Psychopharmacol. 23 (2003) 657-659
4. Rosenberg M. Society and the Adolescent Self-Image. Revised edition (1989), Wesleyan University Press, Middletown, CT